MYUNGIN PHARM.CO., LTD

317450 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩44,100.00
+0.57%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does MYUNGIN PHARM.CO., LTD belong to?
MYUNGIN PHARM.CO., LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.
What is the current share price of 317450?
As of the latest available quote, 317450 traded at ₩44,100.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of 317450?
MYUNGIN PHARM.CO., LTD has a price-to-earnings (P/E) ratio of about 7.91. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of 317450?
The market capitalisation of MYUNGIN PHARM.CO., LTD is approximately ₩643.86B.
Is MYUNGIN PHARM.CO., LTD profitable?
For its latest reported financial year, MYUNGIN PHARM.CO., LTD recorded a net profit margin of about 28.35%.
Does 317450 pay a dividend?
MYUNGIN PHARM.CO., LTD currently has a dividend yield of about 2.08%.
What is the return on equity (ROE) of 317450?
MYUNGIN PHARM.CO., LTD has a return on equity (ROE) of about 10.25%. ROE measures how much profit a company generates relative to shareholders' equity.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.